Discrepant Intracranial and Extracranial Responses to Tarlatamab in Relapsed Small‐Cell Lung Cancer With Untreated Brain Metastases: A Case Report

ABSTRACT Small‐cell lung cancer (SCLC) has a poor prognosis, and the efficacy of tarlatamab for untreated brain metastases remains unclear. We report a case demonstrating a discrepant response between extracranial and intracranial lesions after tarlatamab treatment. A 72‐year‐old man with extensive‐...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Eri Hayashi, Hirohisa Kano, Kayo Nakamura, Takamasa Kondo, Akira Nishioka, Manaya Tanaka, Kotaro Aoe, Shuko Mashimo, Daizo Kishino
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2026-05-01
coleção:	Respirology Case Reports
Assuntos:	brain metastases discrepant response small‐cell lung cancer tarlatamab
Acesso em linha:	https://doi.org/10.1002/rcr2.70615
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!